Armata Pharmaceuticals Inc.
Organization details
- Legal name
- Armata Pharmaceuticals Inc.
- Former names
- AmpliPhi Biosciences Corp Targeted Genetics Corp
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Washington
- Headquarters city
- LOS Angeles
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- ARMP
- Primary stock exchange
- NYSE American
Identifiers
- SEC CIK
- 0000921114
- EIN
- 91-1549568
Board of directors
-
Daniel B. Gilmer · DirectorSince 2026
-
Deborah Birx · Director · Chief Executive OfficerSince 2023
-
Joseph M. Patti · DirectorSince 2023
-
Jules Haimovitz · DirectorSince 2023
-
Kostas D. Odysseas · DirectorSince 2023
-
Robin Kramer · DirectorSince 2023
-
Sarah J. Schlesinger · DirectorSince 2023
-
Todd C. Peterson · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 11, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
99.2%
-
99.2%
-
99.2%
-
99.8%
-
99.8%
-
99.8%
Board connections
4 of this board's directors also sit on 2 other boards. 2 are in the same sector.
-
Innoviva Inc. Same sectorvia Deborah Birx, Jules Haimovitz, Kostas D. Odysseas and Sarah J. Schlesinger
-
Amarin Corporation plc Same sectorvia Kostas D. Odysseas
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 10, 2026 | Deborah Birx Director, Officer (Chief Executive Officer) | Shares withheld for tax | −14,041 | $4.26 | $59,815 |
| Mar 14, 2026 | Kyme Pierre Officer (Chief Business Officer) | Shares withheld for tax | −1,030 | $10.54 | $10,856 |
| Mar 14, 2026 | Deborah Birx Director, Officer (Chief Executive Officer) | Shares withheld for tax | −4,919 | $10.54 | $51,846 |
| Jul 10, 2025 | Deborah Birx Director, Officer (Chief Executive Officer) | Shares withheld for tax | −13,637 | $2.27 | $30,956 |
| Mar 14, 2025 | Kyme Pierre Officer (Chief Business Officer) | Shares withheld for tax | −1,027 | $1.95 | $2,003 |
| Mar 14, 2025 | Deborah Birx Director, Officer (Chief Executive Officer) | Shares withheld for tax | −6,061 | $1.95 | $11,819 |
| Jul 10, 2024 | Deborah Birx Director, Officer (Chief Executive Officer) | Shares withheld for tax | −22,925 | $2.68 | $61,439 |
| Mar 14, 2024 | Rychlik Richard Officer (Corporate Controller and PFO) | Grant or award | +10,000 | — | — |
| Mar 14, 2024 | Deborah Birx Director, Officer (Chief Executive Officer) | Grant or award | +60,000 | — | — |
| Dec 21, 2023 | Deborah Birx Director, Officer (Chief Executive Officer) | Grant or award | +200,000 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Armata Pharmaceuticals Inc.
Who is the CEO of Armata Pharmaceuticals Inc.?
Deborah Birx has been Armata Pharmaceuticals Inc.'s Chief Executive Officer since July 2023.
How many directors are on Armata Pharmaceuticals Inc.'s board?
Armata Pharmaceuticals Inc.'s board has 8 directors: Daniel B. Gilmer, Deborah Birx, Joseph M. Patti, Jules Haimovitz, Kostas D. Odysseas, Robin Kramer, Sarah J. Schlesinger and Todd C. Peterson.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="armata-pharmaceuticals-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.